Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous acetaminophen versus oral ibuprofen for PDA closure in preterm infants
IRCT20260607069688N1Phase 3Recruiting
- Sponsor
- Qom University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in patent ductus arteriosus (PDA) comparing Intravenous acetaminophen with Oral ibuprofen (2 arms). Primary endpoints: Rate of PDA closure confirmed by echocardiography, Need for additional medical treatment and 5 more. Started Jun 2026; status: recruiting.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20260607069688N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260607069688N1.